Physician profile
Kirk E Harum
NPI 1013904614
$23,052.24
in general payments reported to CMS, 2019-2025
57 companies · $4,809 in 2025
The $4,809 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $1,778 · 2021: $1,772 · 2022: $4,723 · 2023: $4,747 · 2024: $3,433 · 2025: $4,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,274 · Travel and Lodging: $3,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,273.55 |
| Travel and Lodging | $3,714.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $4,878.12 | 2022-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $4,079.67 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Medtronic, INC. | $2,874.44 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Relievant Medsystems, INC. | $2,338.80 | 2020-2023 | Intracept |
| Nevro Corp. | $1,961.07 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $1,642.82 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Abbott Laboratories | $353.98 | 2019-2025 | Freestyle Libre 3, Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $341.03 | 2019-2024 | Belbuca |
| Allergan, INC. | $293.84 | 2019-2021 | |
| Forte Bio-Pharma LLC | $290.68 | 2020-2024 | Prolate, Nalocet |
| Abbvie INC. | $273.46 | 2022-2025 | |
| Stimwave Technologies Incorporated | $250.86 | 2020 | |
| Globus Medical, INC. | $245.22 | 2025 | Senza, Vyrsa V1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $242.44 | 2019-2025 | Relistor |
| Biotronik Nro, INC. | $231.11 | 2025 | Prospera |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Harum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.